As of August 7th, BioScrip and Option Care joined together to form a stronger organization that is committed to reshaping the future of infusion healthcare. Recognized for demonstrating the …

2019年8月7日 · BANNOCKBURN, Ill. & DENVER, August 7, 2019 — Option Care Enterprises, Inc. (“Option Care”) and BioScrip, Inc. (“BioScrip”) today announced the successful completion …

2019年3月15日 · DENVER and BANNOCKBURN, Ill., March 15, 2019 — BioScrip, Inc. (NASDAQ: BIOS) (“BioScrip”) and Option Care Enterprises, Inc. (“Option Care”), the nation’s …

Information on acquisition, funding, investors, and executives for BioScrip. Use the PitchBook Platform to explore the full profile.

2019年8月9日 · 拜尔斯普保健公司是一家立足于美国的全国性医药与家庭健康服务供应商。 该公司为患者提供临床管理解决方案、处方药使用和家庭医疗服务。 早在1997年，拜尔斯普保健便已在纳斯达克上市。 Option Care公司则位于伊利诺依州Buffalo Grove，它在医院之外的场所（如患者家里或医生诊所）为患者提供家庭输液治疗和其他医疗保健服务。 家庭输液治疗将药物经由皮下（而不是服用药丸）输送到血液中，在治疗癌症和血友病时，这是一种常用的用药方式。 （ …

2019年8月8日 · With the closure of this merger, legacy BioScrip business can now further help leverage Option Care’s operational efficiency, industrial infrastructure and its top-notch management systems.

BioScrip is the largest independent provider of infusion and home care management solutions, with approximately 2,200 teammates and nearly 80 service locations across the U.S.

2019年3月15日 · DENVER - BioScrip and Option Care Enterprises, two of the largest independent providers of home infusion therapy services, have entered into a definitive merger agreement, the companies announced on March 15.

ELMSFORD, N.Y. -- (BUSINESS WIRE)--Dec. 13, 2012-- BioScrip, Inc. (NASDAQ: BIOS) today announced that it has entered into a definitive agreement to acquire HomeChoice Partners, Inc. (“HomeChoice”), a leading provider of alternate-site infusion pharmacy services, for $70.0 million in …

Option Care Health is the provider of home and alternate site infusion services. With over 5,000 teammates, including approximately 2,900 clinicians, we work compassionately to elevate …